Oligomeric Proanthocyanidin-Enriched Maritime Pine Bark Microcapsules Modulate Melanogenesis-Related Endpoints: Evidence for Pigmentation Balance and Skin-Tone Uniformity

Melanogenesis is influenced by α-MSH signaling, oxidative stress and communication between melanocytes and neighboring skin cells. We tested a BCLC maritime pine bark microcapsule enriched in DP2-DP6 oligomeric proanthocyanidins in an α-MSH-stimulated B16-F10 model and compared the experimental endpoints with published human pigmentation studies. The reference BCLC material contained 62.4% DP2-DP6 within total proanthocyanidins. At 25, 50 and 100 μg/mL, relative melanin content was 91.6%, 84.7% and 78.9% of the α-MSH model; tyrosinase activity was 93.5%, 88.6% and 82.5%, and cell viability remained 93.8-97.8%. Human research with French maritime pine bark extract includes a randomized crossover study of seasonal skin darkening, a randomized placebo-controlled melasma study that measured mMASI and colorimetric contrast, and a randomized study of age-spot pigmentation. A 2026 pilot using a combined Pycnogenol-pomegranate product also reported lower melanin index and higher L* values. The cell data and the established clinical measurement methods support BCLC-specific testing of pigmentation balance and skin-tone uniformity.